Biotie Therapies Cash Flow - Quarterly (NASDAQ:BITI)

Add to My Stocks
$25.8 $0.71 (2.68%) BITI stock closing price Jun 10, 2016 (Closing)

The Biotie Therapies cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Biotie Therapies profits one has to check the income statement and for Biotie Therapies debt one has to check the balance sheet. Biotie Therapies saw a cash impact of $- from the buyback of BITI shares. The cash flow statement helps in the Biotie Therapies stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Biotie Therapies has a negative cash and cash equivalents change of $-4.26M.

View and download details of Biotie Therapies cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--
Net Increase (Decrease) in Assets Liabilities--0.68M
Cash From (used in) Discontinued Operations--
Other Adjustments Net2.79M-1.46M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--0.09M
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments6.99M-6.97M
Other Cash Inflow (Outflow) from Investment Activities--0.02M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-48.8M
Issuance (Repayment) of Debt Securities-33.55M
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-2.09M1.98M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year--
Cash & Equivalents at Year End47.32M51.92M
All figures in USD. M: Millions of USD, B: Billions of USD.

Biotie Therapies stock price history provides insight into historical stock price fluctuations, and Biotie Therapies stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Biotie Therapies had a Net Change in Cash and Cash Equivalents of $-4.26M in the latest quarter 2016 Q1. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Biotie Therapies stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-9.17M for BITI.
  • Cash Flow from investment activities: Biotie Therapies generated $6.99M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for Biotie Therapies.

Quarterly Cash Flow Statements For Biotie Therapies Corp (ADR) Peers

ASSERTIO THERAP cash flow, Axovant Sciences cash flow, Catalyst Pharma cash flow, Pfizer cash flow, Vernalis cash flow